Abstract:Parkinson's Disease (PD) is widely recognized for its impact on the central nervous system. Recent breakthroughs underscore the crucial role of interactions between central and peripheral systems in PD's pathogenesis, highlighting the need for a paradigm shift in PD research. The spotlight is now shifting as we explore beyond the central nervous system, discovering that peripheral changes such as inflammatory dysfunctions may predict the rate of disease progression and severity. However, the cellular mechanisms driving these immunity changes remain largely unknown. Despite over 200 years of research on PD, robust diagnostic or progression biomarkers and disease altering therapeutics are still lacking. Thus, understanding peripheral immune signatures could lead to earlier diagnosis and more effective treatments for PD. Here, we sought to define the transcriptomic alterations of the complete peripheral immune cell compartment by single-cell RNA- and T-cell receptor-sequencing with hopes of uncovering PD signatures and potential peripheral blood biomarkers. Following transcriptional profiling of 78 876 cells from 10 healthy controls and 14 PD donors, we observed five major classes of immune cell types; myeloid (monocytes, dendritic cells) and lymphoid (T, B, natural killer) cells from which we identified 38 cellular subtypes following bioinformatic re-clustering. Comparing immune cell subtypes and phenotypes between PD patients and healthy controls revealed notable features of PD: 1) a significant shift of classical CD14+ monocytes towards an activated CD14+/CD83+ state, 2) changes in lymphocyte subtypes abundance, including a significant decrease in CD4+ naive and mucosal-associated invariant T-cells subtypes, along with an increase in CD56+ natural killer cells, 3) the identification by T-cell receptor sequencing of several PD specific T-cell clones shared between multiple patients, suggesting the implication of common epitopes in PD pathogenesis, 4) a notable increase in the expression of activation signature genes, including the AP-1 stress-response transcription factor complex, across all PD cell types. This signal was not present in atypical Parkinsonism patients with multiple systems atrophy or progressive supranuclear palsy. Overall, we present a comprehensive atlas of peripheral blood mononuclear cells from control and PD patients which should serve as a tool to improve our understanding of the role the immune cell landscape plays in PD pathogenesis.

Peripheral immune cell response to stimulation stratifies Parkinson's disease progression from prodromal to clinical stages

Cytokine and Chemokine Map of Peripheral Specific Immune Cell Subsets in Parkinson's Disease

Single-cell RNA sequencing reveals peripheral immunological features in Parkinson's Disease

Parkinson's Disease Peripheral Immune Biomarker Profile: a Multicentre, Cross-Sectional and Longitudinal Study

Immunological shifts during early-stage Parkinson’s disease identified with DNA methylation data on longitudinally collected blood samples

Association Between Peripheral Adaptive Immune Markers and Disease Progression in Parkinson's Disease.

Mapping the peripheral immune landscape of Parkinson's disease patients with single-cell sequencing

Cytokine and chemokine map of peripheral specific immune cell subsets in Parkinson’s disease

Periphery and brain, innate and adaptive immunity in Parkinson's disease

Dysregulation of peripheral monocytes and pro-inflammation of alpha-synuclein in Parkinson's disease

Immune Profiling of Parkinson’s Disease Revealed Its Association with a Subset of Infiltrating Cells and Signature Genes

Early-to-mid idiopathic Parkinson’s disease shows a more cytotoxic but declined CD8-regulatory peripheral immune profile

Molecular Features of Parkinson's Disease in Patient‐Derived Midbrain Dopaminergic Neurons

Specific immune status in Parkinson’s disease at different ages of onset

Alterations of Peripheral Lymphocyte Subsets in Isolated Rapid Eye Movement Sleep Behavior Disorder

Brain microglia activation and peripheral adaptive immunity in Parkinson's disease: a multimodal PET study

The systemic immune response in Parkinson's disease: focus on the peripheral immune component

Inflammation and immune dysfunction in Parkinson disease

The role of peripheral inflammation-related biomarkers in distinguishing Parkinson's disease

Immune-related biomarkers for Parkinson's disease

Inflammatory Blood Biomarkers Are Associated with Long-Term Clinical Disease Severity in Parkinson's Disease